JP2012144566A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012144566A5 JP2012144566A5 JP2012096909A JP2012096909A JP2012144566A5 JP 2012144566 A5 JP2012144566 A5 JP 2012144566A5 JP 2012096909 A JP2012096909 A JP 2012096909A JP 2012096909 A JP2012096909 A JP 2012096909A JP 2012144566 A5 JP2012144566 A5 JP 2012144566A5
- Authority
- JP
- Japan
- Prior art keywords
- active ingredient
- selecting
- agent
- hyaluronic acid
- promoting effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000004480 active ingredient Substances 0.000 claims 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- BTCSSZJGUNDROE-UHFFFAOYSA-N gamma-aminobutyric acid Chemical compound NCCCC(O)=O BTCSSZJGUNDROE-UHFFFAOYSA-N 0.000 claims 2
- 229920002674 hyaluronan Polymers 0.000 claims 2
- 229960003160 hyaluronic acid Drugs 0.000 claims 2
- 102000007236 involucrin Human genes 0.000 claims 2
- 108010033564 involucrin Proteins 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 230000001737 promoting effect Effects 0.000 claims 2
- OGNSCSPNOLGXSM-UHFFFAOYSA-N (+/-)-DABA Natural products NCCC(N)C(O)=O OGNSCSPNOLGXSM-UHFFFAOYSA-N 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 210000005175 epidermal keratinocyte Anatomy 0.000 claims 1
- 229960003692 gamma aminobutyric acid Drugs 0.000 claims 1
- 210000002510 keratinocyte Anatomy 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012096909A JP2012144566A (en) | 2012-04-20 | 2012-04-20 | Method for selecting active constituent in epidermal function ameliorating agent |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2012096909A JP2012144566A (en) | 2012-04-20 | 2012-04-20 | Method for selecting active constituent in epidermal function ameliorating agent |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2007278483A Division JP2009107931A (en) | 2007-10-26 | 2007-10-26 | Skin function improver |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2012144566A JP2012144566A (en) | 2012-08-02 |
JP2012144566A5 true JP2012144566A5 (en) | 2012-11-15 |
Family
ID=46788486
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2012096909A Pending JP2012144566A (en) | 2012-04-20 | 2012-04-20 | Method for selecting active constituent in epidermal function ameliorating agent |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2012144566A (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP7642955B2 (en) | 2021-02-04 | 2025-03-11 | 株式会社ファンケル | Composition for promoting olfactory receptor expression |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5826726B2 (en) * | 1975-06-13 | 1983-06-04 | カネボウ株式会社 | Keshiyouriyo |
JPH0363211A (en) * | 1989-08-02 | 1991-03-19 | Kanebo Ltd | Cosmetic for fair skin and beauty |
-
2012
- 2012-04-20 JP JP2012096909A patent/JP2012144566A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2827842A4 (en) | Cyclodextrin-based microemulsions, and dermatological uses thereof | |
PH12015500561A1 (en) | Therapeutic nanoparticles comprising a therapeutic agent and methods of making and using same | |
WO2012100097A3 (en) | Topical minocycline compositions and methods of using the same | |
GB201217538D0 (en) | Improvements in or relating to scanning laser ophthalmoscopes | |
ZA201501541B (en) | Supported catalyst and active form thereof, and preparation method and use thereof | |
IL227625A0 (en) | Nanoparticle compositions, formulations thereof, and uses therefor | |
JP2012240149A5 (en) | ||
FR3000095B1 (en) | COMPOSITION COMPRISING 2,3,3,3-TETRAFLUOROPROPENE AND 1,2-DIFLUOROETHYLENE | |
JP2015512729A5 (en) | ||
BR112014023405A2 (en) | chitosan derivative nanoparticle, composition comprising the nanoparticle and in vitro method for delivering nucleic acid molecule to a cell | |
PH12015500900A1 (en) | A stabilized pemetrexed formulation | |
BR112014026149A2 (en) | Method for the preparation of 2,4-dihydroxybutyric acid (2,4-dhb) and microorganism. | |
FR2975004B1 (en) | NEW ANTI-REDNESS ACTIVE INGREDIENTS AND COSMETIC COMPOSITIONS COMPRISING THE SAME | |
DK2667856T3 (en) | MEDICINAL PRODUCT CONTAINING A DRY PREPARATOR COMPOSITION INCLUDING ARIPIPRAZOLE AS AN ACTIVE INGREDIENT AND A DRY PUMP COMPOSITION INCLUDING ARIPIPRAZOLE AS AN ACTIVE INGREDIENT | |
BR112015014885A2 (en) | combination of active agents, cosmetic and / or dermatological composition and process for preparing an active agent composition. | |
ZA201402433B (en) | An aqueous photo-protective personal care composition | |
IL233926B (en) | Method for producing 3,5-bis(fluoroalkyl)-pyrazol-4-carboxylic acid derivatives and 3,5-bis(fluoroalkyl)-pyrazoles | |
PL2753182T3 (en) | Active agents against pseudomonas species causing rotting diseases in mushroom production, their use and compositions containing them | |
ZA201408026B (en) | Flouro-substituted (3r,2r,5s)-5-guanidino-4-acylamino-3-(pentan-3-yloxy)cyclohexene-1-carbixylic acids, esters thereof and method for the use thereof | |
JP2012144566A5 (en) | ||
EP2857503A4 (en) | Method for stabilizing ascorbic acid oxidase | |
BR112014007022A8 (en) | pharmaceutical composition, method of improving absorption in the small intestine and use of a pharmaceutical composition. | |
WO2013100585A3 (en) | Adonis amurensis extract or anti-cancer composition using same as an active ingredient | |
WO2012146736A8 (en) | Use of 3-carboxy-n-ethyl-n,n-dimethylpropan-1-aminium salts in the treatment of cardiovascular disease | |
FI20105323L (en) | Method for producing perforated sheet-like or strip-like pieces for use in the construction industry, and piece produced by the method |